

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.85170556 |
| 2 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.85170556 |
| 3 | modulation by symbiont of host immune response (GO:0052553) | 4.85170556 |
| 4 | positive regulation by symbiont of host defense response (GO:0052509) | 4.85170556 |
| 5 | modulation by symbiont of host defense response (GO:0052031) | 4.85170556 |
| 6 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.85170556 |
| 7 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.67769392 |
| 8 | positive regulation of interferon-alpha production (GO:0032727) | 4.57482442 |
| 9 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.38562806 |
| 10 | regulation of interferon-alpha production (GO:0032647) | 4.36005104 |
| 11 | response to peptidoglycan (GO:0032494) | 4.22284621 |
| 12 | macrophage activation involved in immune response (GO:0002281) | 4.16555327 |
| 13 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.14978108 |
| 14 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 4.10458516 |
| 15 | neutrophil activation involved in immune response (GO:0002283) | 4.09690143 |
| 16 | negative regulation of cell killing (GO:0031342) | 4.00712761 |
| 17 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.00712761 |
| 18 | positive regulation of B cell differentiation (GO:0045579) | 3.96291463 |
| 19 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.86582638 |
| 20 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.80543718 |
| 21 | negative thymic T cell selection (GO:0045060) | 3.78835639 |
| 22 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.76859042 |
| 23 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.73945271 |
| 24 | negative T cell selection (GO:0043383) | 3.71596471 |
| 25 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.70772847 |
| 26 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.70621953 |
| 27 | negative regulation of interleukin-12 production (GO:0032695) | 3.65967148 |
| 28 | B cell mediated immunity (GO:0019724) | 3.65940712 |
| 29 | regulation of antigen processing and presentation (GO:0002577) | 3.60531392 |
| 30 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.59128077 |
| 31 | macrophage activation (GO:0042116) | 3.56804703 |
| 32 | natural killer cell activation involved in immune response (GO:0002323) | 3.56496402 |
| 33 | regulation of MHC class I biosynthetic process (GO:0045343) | 3.56178125 |
| 34 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.55954492 |
| 35 | negative regulation of viral genome replication (GO:0045071) | 3.54339424 |
| 36 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 3.51963726 |
| 37 | cellular response to exogenous dsRNA (GO:0071360) | 3.50233837 |
| 38 | granulocyte activation (GO:0036230) | 3.48791878 |
| 39 | negative regulation of T cell mediated immunity (GO:0002710) | 3.42356926 |
| 40 | regulation of tolerance induction (GO:0002643) | 3.40096806 |
| 41 | T cell migration (GO:0072678) | 3.37353012 |
| 42 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 3.36327295 |
| 43 | regulation of B cell differentiation (GO:0045577) | 3.35346580 |
| 44 | positive thymic T cell selection (GO:0045059) | 3.35217611 |
| 45 | neutrophil activation (GO:0042119) | 3.34956787 |
| 46 | positive regulation of granulocyte differentiation (GO:0030854) | 3.32430938 |
| 47 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.30321295 |
| 48 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.29491478 |
| 49 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.29041591 |
| 50 | positive regulation of mast cell degranulation (GO:0043306) | 3.29041591 |
| 51 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.28690446 |
| 52 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.28690446 |
| 53 | germinal center formation (GO:0002467) | 3.27604213 |
| 54 | lymph vessel development (GO:0001945) | 3.27303834 |
| 55 | respiratory burst (GO:0045730) | 3.26821939 |
| 56 | positive regulation of defense response to virus by host (GO:0002230) | 3.25720359 |
| 57 | microglial cell activation (GO:0001774) | 3.24372624 |
| 58 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 3.23561098 |
| 59 | response to interleukin-15 (GO:0070672) | 3.22848561 |
| 60 | positive regulation of tolerance induction (GO:0002645) | 3.22815294 |
| 61 | cellular response to interleukin-15 (GO:0071350) | 3.22380697 |
| 62 | regulation of T cell tolerance induction (GO:0002664) | 3.22137201 |
| 63 | immunoglobulin mediated immune response (GO:0016064) | 3.21277750 |
| 64 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.19374105 |
| 65 | response to host immune response (GO:0052572) | 3.19374105 |
| 66 | response to type I interferon (GO:0034340) | 3.18438018 |
| 67 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.17710294 |
| 68 | superoxide anion generation (GO:0042554) | 3.16702734 |
| 69 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.15805098 |
| 70 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 3.14485684 |
| 71 | detection of molecule of bacterial origin (GO:0032490) | 3.14022943 |
| 72 | Peyers patch development (GO:0048541) | 3.13024972 |
| 73 | mucosal-associated lymphoid tissue development (GO:0048537) | 3.13024972 |
| 74 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.12984802 |
| 75 | T-helper 1 type immune response (GO:0042088) | 3.12091611 |
| 76 | cellular response to type I interferon (GO:0071357) | 3.11430293 |
| 77 | type I interferon signaling pathway (GO:0060337) | 3.11430293 |
| 78 | detection of bacterium (GO:0016045) | 3.11014720 |
| 79 | regulation of chemokine biosynthetic process (GO:0045073) | 3.10811956 |
| 80 | * B cell receptor signaling pathway (GO:0050853) | 3.10684070 |
| 81 | positive regulation of interferon-beta production (GO:0032728) | 3.10314838 |
| 82 | I-kappaB phosphorylation (GO:0007252) | 3.08081354 |
| 83 | T cell selection (GO:0045058) | 3.03413438 |
| 84 | positive regulation of interleukin-1 secretion (GO:0050716) | 3.02414337 |
| 85 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.02259215 |
| 86 | response to host (GO:0075136) | 3.02259215 |
| 87 | response to host defenses (GO:0052200) | 3.02259215 |
| 88 | myeloid dendritic cell activation (GO:0001773) | 3.01973011 |
| 89 | mast cell activation (GO:0045576) | 3.01499113 |
| 90 | positive regulation of antigen processing and presentation (GO:0002579) | 3.01195566 |
| 91 | defense response to protozoan (GO:0042832) | 3.00232936 |
| 92 | cellular response to interferon-beta (GO:0035458) | 2.99987112 |
| 93 | interferon-gamma production (GO:0032609) | 2.99406706 |
| 94 | lymphocyte chemotaxis (GO:0048247) | 2.99207737 |
| 95 | regulation of T-helper cell differentiation (GO:0045622) | 2.98632442 |
| 96 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.97989237 |
| 97 | regulation of interleukin-12 production (GO:0032655) | 2.97463174 |
| 98 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.97113964 |
| 99 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.96445825 |
| 100 | cellular extravasation (GO:0045123) | 2.96406960 |
| 101 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.95708277 |
| 102 | thymic T cell selection (GO:0045061) | 2.94112973 |
| 103 | positive T cell selection (GO:0043368) | 2.93780126 |
| 104 | regulation of germinal center formation (GO:0002634) | 2.92991950 |
| 105 | myeloid cell activation involved in immune response (GO:0002275) | 2.92187358 |
| 106 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.90136885 |
| 107 | regulation of superoxide anion generation (GO:0032928) | 2.89749717 |
| 108 | response to interferon-gamma (GO:0034341) | 2.89250073 |
| 109 | defense response to virus (GO:0051607) | 2.89223002 |
| 110 | tolerance induction (GO:0002507) | 2.88762096 |
| 111 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.88404141 |
| 112 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 2.87798866 |
| 113 | regulation of growth of symbiont in host (GO:0044126) | 2.87798866 |
| 114 | negative regulation of growth of symbiont in host (GO:0044130) | 2.87798866 |
| 115 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 2.87798866 |
| 116 | T cell activation involved in immune response (GO:0002286) | 2.87508558 |
| 117 | mature B cell differentiation involved in immune response (GO:0002313) | 2.85867121 |
| 118 | regulation of alpha-beta T cell activation (GO:0046634) | 2.84655911 |
| 119 | positive regulation of interleukin-2 production (GO:0032743) | 2.83641226 |
| 120 | regulation of fever generation (GO:0031620) | 2.82666566 |
| 121 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.82480878 |
| 122 | regulation of mast cell degranulation (GO:0043304) | 2.82272638 |
| 123 | positive regulation of interleukin-12 production (GO:0032735) | 2.80666133 |
| 124 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.80195850 |
| 125 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.79521615 |
| 126 | positive regulation of mast cell activation (GO:0033005) | 2.75627350 |
| 127 | response to muramyl dipeptide (GO:0032495) | 2.74640793 |
| 128 | response to interferon-beta (GO:0035456) | 2.73921037 |
| 129 | regulation of monocyte chemotaxis (GO:0090025) | 2.72703980 |
| 130 | regulation of activation of Janus kinase activity (GO:0010533) | 2.72235159 |
| 131 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.71995500 |
| 132 | positive regulation of macrophage differentiation (GO:0045651) | 2.71029220 |
| 133 | positive regulation of type 2 immune response (GO:0002830) | 2.70234110 |
| 134 | regulation of platelet activation (GO:0010543) | 2.68671753 |
| 135 | positive regulation of heat generation (GO:0031652) | 2.68632789 |
| 136 | positive regulation of chemokine production (GO:0032722) | 2.68090574 |
| 137 | cellular response to interferon-gamma (GO:0071346) | 2.67820799 |
| 138 | response to protozoan (GO:0001562) | 2.67464404 |
| 139 | detection of other organism (GO:0098543) | 2.67141882 |
| 140 | regulation of gamma-delta T cell activation (GO:0046643) | 2.66513990 |
| 141 | eosinophil chemotaxis (GO:0048245) | 2.65230790 |
| 142 | low-density lipoprotein particle remodeling (GO:0034374) | 2.64736920 |
| 143 | B cell proliferation (GO:0042100) | 2.64513945 |
| 144 | detection of external biotic stimulus (GO:0098581) | 2.63699579 |
| 145 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.62605104 |
| 146 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.62427421 |
| 147 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.62165803 |
| 148 | leukocyte cell-cell adhesion (GO:0007159) | 2.62076385 |
| 149 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.61561033 |
| 150 | positive regulation of tumor necrosis factor production (GO:0032760) | 2.61369303 |
| 151 | cytokine secretion (GO:0050663) | 2.61274104 |
| 152 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 2.61082965 |
| 153 | leukocyte tethering or rolling (GO:0050901) | 2.60319743 |
| 154 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.59658946 |
| 155 | neutrophil chemotaxis (GO:0030593) | 2.59329361 |
| 156 | myeloid leukocyte activation (GO:0002274) | 2.58997507 |
| 157 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.58497126 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 6.59041595 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.12651880 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.99537895 |
| 4 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.22890738 |
| 5 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.02336495 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.73863054 |
| 7 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.67053199 |
| 8 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.32150341 |
| 9 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.04761583 |
| 10 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.77314047 |
| 11 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.75214953 |
| 12 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.70746618 |
| 13 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.68717430 |
| 14 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.64794051 |
| 15 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.54831423 |
| 16 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.48747311 |
| 17 | * RUNX_20019798_ChIP-Seq_JUKART_Human | 2.42847339 |
| 18 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.37264635 |
| 19 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.24521350 |
| 20 | MYC_22102868_ChIP-Seq_BL_Human | 2.23044255 |
| 21 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.16839830 |
| 22 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.16426937 |
| 23 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.08498851 |
| 24 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.98901290 |
| 25 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.92206693 |
| 26 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.84184567 |
| 27 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.80973542 |
| 28 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.77059153 |
| 29 | * VDR_24787735_ChIP-Seq_THP-1_Human | 1.75260733 |
| 30 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.72685906 |
| 31 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.72446505 |
| 32 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.63193991 |
| 33 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.62941385 |
| 34 | MAF_26560356_Chip-Seq_TH2_Human | 1.55499453 |
| 35 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.55306557 |
| 36 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.53871231 |
| 37 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.52172615 |
| 38 | * MYB_26560356_Chip-Seq_TH2_Human | 1.51696960 |
| 39 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.50734439 |
| 40 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.47904691 |
| 41 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.46643757 |
| 42 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.44704537 |
| 43 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.44697571 |
| 44 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.41715032 |
| 45 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.39996581 |
| 46 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.35288120 |
| 47 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.34994379 |
| 48 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.34194064 |
| 49 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.33678078 |
| 50 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.33120633 |
| 51 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.30119942 |
| 52 | SPI1_23127762_ChIP-Seq_K562_Human | 1.29065236 |
| 53 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.28591146 |
| 54 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.26431613 |
| 55 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.26048325 |
| 56 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.23726124 |
| 57 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.23184228 |
| 58 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.23074068 |
| 59 | MYB_26560356_Chip-Seq_TH1_Human | 1.21448283 |
| 60 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.21152810 |
| 61 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.20539054 |
| 62 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.18477471 |
| 63 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.14800012 |
| 64 | MAF_26560356_Chip-Seq_TH1_Human | 1.14033772 |
| 65 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.13101957 |
| 66 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.13075530 |
| 67 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.11519529 |
| 68 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.10632715 |
| 69 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.10242611 |
| 70 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.10178365 |
| 71 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.10033276 |
| 72 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.09004096 |
| 73 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.06116242 |
| 74 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.04425290 |
| 75 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.04073708 |
| 76 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.03257563 |
| 77 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.02760926 |
| 78 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.01210729 |
| 79 | SMRT_27268052_Chip-Seq_Bcells_Human | 1.00748260 |
| 80 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.99827353 |
| 81 | GATA1_22025678_ChIP-Seq_K562_Human | 0.99778281 |
| 82 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.98597932 |
| 83 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.97794442 |
| 84 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.97706651 |
| 85 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.91926604 |
| 86 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.91759410 |
| 87 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.90327087 |
| 88 | GATA2_19941826_ChIP-Seq_K562_Human | 0.89915275 |
| 89 | * KDM2B_26808549_Chip-Seq_DND41_Human | 0.89615902 |
| 90 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.88734505 |
| 91 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.88582823 |
| 92 | CJUN_26792858_Chip-Seq_BT549_Human | 0.88089741 |
| 93 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 0.87043104 |
| 94 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.86815693 |
| 95 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.86519157 |
| 96 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.86376904 |
| 97 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.85584143 |
| 98 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.85070068 |
| 99 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.84858504 |
| 100 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.84836660 |
| 101 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.84481819 |
| 102 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.83901560 |
| 103 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.83790755 |
| 104 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.83468501 |
| 105 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.81946106 |
| 106 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.81665863 |
| 107 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.81659178 |
| 108 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.81522602 |
| 109 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.81522602 |
| 110 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.81215736 |
| 111 | GATA1_19941826_ChIP-Seq_K562_Human | 0.80844671 |
| 112 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.80205960 |
| 113 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.79905417 |
| 114 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.78514494 |
| 115 | GATA3_26560356_Chip-Seq_TH1_Human | 0.78504458 |
| 116 | GATA3_26560356_Chip-Seq_TH2_Human | 0.78295557 |
| 117 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.77872426 |
| 118 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.76545452 |
| 119 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.76409977 |
| 120 | UTX_26944678_Chip-Seq_JUKART_Human | 0.75523629 |
| 121 | RXR_22108803_ChIP-Seq_LS180_Human | 0.75172618 |
| 122 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.74942366 |
| 123 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.74777158 |
| 124 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.74202224 |
| 125 | P300_27268052_Chip-Seq_Bcells_Human | 0.74073742 |
| 126 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.74073018 |
| 127 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.73780417 |
| 128 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.73481937 |
| 129 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.73241417 |
| 130 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.73241417 |
| 131 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.72846458 |
| 132 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.72041805 |
| 133 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.71647486 |
| 134 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.71508561 |
| 135 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.71360610 |
| 136 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.70210231 |
| 137 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.68253768 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003724_increased_susceptibility_to | 4.27259295 |
| 2 | MP0001835_abnormal_antigen_presentation | 4.21702359 |
| 3 | MP0009785_altered_susceptibility_to | 3.40497595 |
| 4 | MP0002148_abnormal_hypersensitivity_rea | 3.14273397 |
| 5 | MP0005387_immune_system_phenotype | 3.01639423 |
| 6 | MP0001790_abnormal_immune_system | 3.01639423 |
| 7 | * MP0001800_abnormal_humoral_immune | 2.90742701 |
| 8 | * MP0005000_abnormal_immune_tolerance | 2.81898837 |
| 9 | MP0002419_abnormal_innate_immunity | 2.75317229 |
| 10 | MP0005167_abnormal_blood-brain_barrier | 2.75036865 |
| 11 | MP0003436_decreased_susceptibility_to | 2.73624286 |
| 12 | MP0001879_abnormal_lymphatic_vessel | 2.73208437 |
| 13 | MP0002452_abnormal_antigen_presenting | 2.71689725 |
| 14 | MP0005025_abnormal_response_to | 2.67890871 |
| 15 | MP0005671_abnormal_response_to | 2.66709953 |
| 16 | MP0003303_peritoneal_inflammation | 2.63307671 |
| 17 | MP0010368_abnormal_lymphatic_system | 2.50859359 |
| 18 | MP0006082_CNS_inflammation | 2.45723642 |
| 19 | MP0002723_abnormal_immune_serum | 2.41323473 |
| 20 | MP0000685_abnormal_immune_system | 2.33564077 |
| 21 | MP0009764_decreased_sensitivity_to | 2.24159762 |
| 22 | * MP0001819_abnormal_immune_cell | 2.18994749 |
| 23 | * MP0002420_abnormal_adaptive_immunity | 2.18200136 |
| 24 | MP0006054_spinal_hemorrhage | 2.14598964 |
| 25 | MP0010155_abnormal_intestine_physiology | 2.04813158 |
| 26 | MP0003828_pulmonary_edema | 1.84198470 |
| 27 | MP0004947_skin_inflammation | 1.77367202 |
| 28 | MP0003075_altered_response_to | 1.75561070 |
| 29 | MP0001533_abnormal_skeleton_physiology | 1.75425720 |
| 30 | MP0003300_gastrointestinal_ulcer | 1.75050821 |
| 31 | MP0005464_abnormal_platelet_physiology | 1.74514102 |
| 32 | MP0001873_stomach_inflammation | 1.70075916 |
| 33 | * MP0001845_abnormal_inflammatory_respons | 1.69237315 |
| 34 | MP0002006_tumorigenesis | 1.68995954 |
| 35 | MP0003690_abnormal_glial_cell | 1.68930701 |
| 36 | MP0001853_heart_inflammation | 1.68656598 |
| 37 | MP0005058_abnormal_lysosome_morphology | 1.62912380 |
| 38 | MP0005451_abnormal_body_composition | 1.61886775 |
| 39 | MP0005166_decreased_susceptibility_to | 1.60031759 |
| 40 | MP0003191_abnormal_cellular_cholesterol | 1.59313864 |
| 41 | MP0002405_respiratory_system_inflammati | 1.55625524 |
| 42 | MP0008469_abnormal_protein_level | 1.53582143 |
| 43 | MP0000703_abnormal_thymus_morphology | 1.52525786 |
| 44 | MP0000716_abnormal_immune_system | 1.51540415 |
| 45 | MP0003172_abnormal_lysosome_physiology | 1.47084500 |
| 46 | MP0000343_altered_response_to | 1.45515239 |
| 47 | MP0002398_abnormal_bone_marrow | 1.43605779 |
| 48 | MP0005360_urolithiasis | 1.34556452 |
| 49 | MP0002277_abnormal_respiratory_mucosa | 1.34257322 |
| 50 | MP0003646_muscle_fatigue | 1.34184741 |
| 51 | MP0002166_altered_tumor_susceptibility | 1.34104262 |
| 52 | MP0000689_abnormal_spleen_morphology | 1.32385981 |
| 53 | MP0000249_abnormal_blood_vessel | 1.29569307 |
| 54 | MP0003448_altered_tumor_morphology | 1.28711670 |
| 55 | MP0002138_abnormal_hepatobiliary_system | 1.28387863 |
| 56 | MP0004808_abnormal_hematopoietic_stem | 1.26534520 |
| 57 | MP0005164_abnormal_response_to | 1.25769502 |
| 58 | MP0009278_abnormal_bone_marrow | 1.24861241 |
| 59 | MP0004510_myositis | 1.24711788 |
| 60 | MP0002429_abnormal_blood_cell | 1.20557423 |
| 61 | MP0003656_abnormal_erythrocyte_physiolo | 1.19474435 |
| 62 | MP0000465_gastrointestinal_hemorrhage | 1.17903866 |
| 63 | MP0003866_abnormal_defecation | 1.17746685 |
| 64 | MP0010234_abnormal_vibrissa_follicle | 1.15556796 |
| 65 | MP0008004_abnormal_stomach_pH | 1.15515112 |
| 66 | MP0002998_abnormal_bone_remodeling | 1.13788159 |
| 67 | MP0005310_abnormal_salivary_gland | 1.12566985 |
| 68 | MP0002722_abnormal_immune_system | 1.10400811 |
| 69 | MP0003183_abnormal_peptide_metabolism | 1.10294084 |
| 70 | MP0003763_abnormal_thymus_physiology | 1.07539966 |
| 71 | MP0001851_eye_inflammation | 1.07146498 |
| 72 | MP0002933_joint_inflammation | 1.04683250 |
| 73 | MP0002254_reproductive_system_inflammat | 1.04483577 |
| 74 | MP0009333_abnormal_splenocyte_physiolog | 1.04261508 |
| 75 | MP0005670_abnormal_white_adipose | 1.03860080 |
| 76 | MP0000767_abnormal_smooth_muscle | 1.03191390 |
| 77 | MP0003045_fibrosis | 1.01675695 |
| 78 | MP0000858_altered_metastatic_potential | 0.98264840 |
| 79 | MP0005075_abnormal_melanosome_morpholog | 0.97591102 |
| 80 | MP0003806_abnormal_nucleotide_metabolis | 0.97322483 |
| 81 | MP0004782_abnormal_surfactant_physiolog | 0.95971772 |
| 82 | MP0009763_increased_sensitivity_to | 0.93365157 |
| 83 | MP0005377_hearing/vestibular/ear_phenot | 0.91438348 |
| 84 | MP0003878_abnormal_ear_physiology | 0.91438348 |
| 85 | MP0002009_preneoplasia | 0.90165602 |
| 86 | MP0001663_abnormal_digestive_system | 0.89660497 |
| 87 | MP0002136_abnormal_kidney_physiology | 0.89484062 |
| 88 | MP0003279_aneurysm | 0.87731797 |
| 89 | MP0004883_abnormal_blood_vessel | 0.85944119 |
| 90 | MP0003453_abnormal_keratinocyte_physiol | 0.83619162 |
| 91 | MP0010352_gastrointestinal_tract_polyps | 0.82906230 |
| 92 | MP0002332_abnormal_exercise_endurance | 0.81810022 |
| 93 | MP0004381_abnormal_hair_follicle | 0.81365934 |
| 94 | MP0008057_abnormal_DNA_replication | 0.81157418 |
| 95 | MP0009765_abnormal_xenobiotic_induced | 0.79719573 |
| 96 | MP0005171_absent_coat_pigmentation | 0.77726979 |
| 97 | MP0002396_abnormal_hematopoietic_system | 0.76179069 |
| 98 | MP0005390_skeleton_phenotype | 0.74299396 |
| 99 | MP0002019_abnormal_tumor_incidence | 0.73435999 |
| 100 | MP0000604_amyloidosis | 0.72605423 |
| 101 | MP0005165_increased_susceptibility_to | 0.72217909 |
| 102 | MP0009840_abnormal_foam_cell | 0.72162316 |
| 103 | MP0000015_abnormal_ear_pigmentation | 0.72026538 |
| 104 | MP0000569_abnormal_digit_pigmentation | 0.71412886 |
| 105 | MP0004147_increased_porphyrin_level | 0.70214530 |
| 106 | MP0005266_abnormal_metabolism | 0.68042472 |
| 107 | MP0009643_abnormal_urine_homeostasis | 0.65749603 |
| 108 | MP0002132_abnormal_respiratory_system | 0.63568213 |
| 109 | MP0000490_abnormal_crypts_of | 0.63436806 |
| 110 | MP0003186_abnormal_redox_activity | 0.62760670 |
| 111 | MP0000609_abnormal_liver_physiology | 0.62162605 |
| 112 | MP0005397_hematopoietic_system_phenotyp | 0.60804197 |
| 113 | MP0001545_abnormal_hematopoietic_system | 0.60804197 |
| 114 | MP0005319_abnormal_enzyme/_coenzyme | 0.60025540 |
| 115 | MP0008874_decreased_physiological_sensi | 0.55524737 |
| 116 | MP0005076_abnormal_cell_differentiation | 0.55189570 |
| 117 | MP0003566_abnormal_cell_adhesion | 0.54944106 |
| 118 | MP0005085_abnormal_gallbladder_physiolo | 0.54812172 |
| 119 | MP0002163_abnormal_gland_morphology | 0.52975403 |
| 120 | * MP0002693_abnormal_pancreas_physiology | 0.52547435 |
| 121 | MP0002139_abnormal_hepatobiliary_system | 0.52490956 |
| 122 | MP0005535_abnormal_body_temperature | 0.48314409 |
| 123 | MP0006036_abnormal_mitochondrial_physio | 0.47525384 |
| 124 | MP0005376_homeostasis/metabolism_phenot | 0.47356438 |
| 125 | MP0001501_abnormal_sleep_pattern | 0.46321833 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 5.71887417 |
| 2 | Recurrent bacterial skin infections (HP:0005406) | 5.23341640 |
| 3 | Eczematoid dermatitis (HP:0000976) | 5.05581949 |
| 4 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.57969116 |
| 5 | Agammaglobulinemia (HP:0004432) | 4.54042304 |
| 6 | Pustule (HP:0200039) | 4.30275252 |
| 7 | Autoimmune thrombocytopenia (HP:0001973) | 4.22449287 |
| 8 | Systemic lupus erythematosus (HP:0002725) | 4.01012737 |
| 9 | Recurrent viral infections (HP:0004429) | 3.81300183 |
| 10 | Spontaneous hematomas (HP:0007420) | 3.80892134 |
| 11 | Mediastinal lymphadenopathy (HP:0100721) | 3.80253175 |
| 12 | Colitis (HP:0002583) | 3.80007180 |
| 13 | Myositis (HP:0100614) | 3.73058198 |
| 14 | Cellulitis (HP:0100658) | 3.72640086 |
| 15 | Vasculitis (HP:0002633) | 3.60089362 |
| 16 | Gastrointestinal stroma tumor (HP:0100723) | 3.55179667 |
| 17 | Orchitis (HP:0100796) | 3.54126191 |
| 18 | Granulocytopenia (HP:0001913) | 3.48613225 |
| 19 | Meningitis (HP:0001287) | 3.48144487 |
| 20 | Recurrent skin infections (HP:0001581) | 3.48035765 |
| 21 | Recurrent fungal infections (HP:0002841) | 3.46063159 |
| 22 | Optic neuritis (HP:0100653) | 3.41861162 |
| 23 | Retrobulbar optic neuritis (HP:0100654) | 3.41861162 |
| 24 | Hematochezia (HP:0002573) | 3.35463219 |
| 25 | Inflammation of the large intestine (HP:0002037) | 3.34812510 |
| 26 | Severe combined immunodeficiency (HP:0004430) | 3.26400127 |
| 27 | Abnormality of macrophages (HP:0004311) | 3.21723436 |
| 28 | Vacuolated lymphocytes (HP:0001922) | 3.21288068 |
| 29 | Gingivitis (HP:0000230) | 3.15109300 |
| 30 | Glomerulonephritis (HP:0000099) | 3.13186135 |
| 31 | Prostate neoplasm (HP:0100787) | 3.06823462 |
| 32 | IgG deficiency (HP:0004315) | 3.05596620 |
| 33 | Gastrointestinal inflammation (HP:0004386) | 3.05521569 |
| 34 | Chronic diarrhea (HP:0002028) | 3.05512752 |
| 35 | Recurrent pneumonia (HP:0006532) | 3.05018055 |
| 36 | Nasal polyposis (HP:0100582) | 2.99331379 |
| 37 | Thick nail (HP:0001805) | 2.93962731 |
| 38 | Osteomyelitis (HP:0002754) | 2.93807958 |
| 39 | Abnormality of eosinophils (HP:0001879) | 2.93675793 |
| 40 | Pulmonary infiltrates (HP:0002113) | 2.88042177 |
| 41 | Recurrent sinusitis (HP:0011108) | 2.87261335 |
| 42 | Stomatitis (HP:0010280) | 2.83829234 |
| 43 | Periodontitis (HP:0000704) | 2.83169612 |
| 44 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.81444662 |
| 45 | Gastrointestinal infarctions (HP:0005244) | 2.80156123 |
| 46 | Bronchitis (HP:0012387) | 2.79916786 |
| 47 | Panhypogammaglobulinemia (HP:0003139) | 2.77636122 |
| 48 | Recurrent lower respiratory tract infections (HP:0002783) | 2.72899498 |
| 49 | Chronic obstructive pulmonary disease (HP:0006510) | 2.72892261 |
| 50 | Obstructive lung disease (HP:0006536) | 2.72892261 |
| 51 | Recurrent bronchitis (HP:0002837) | 2.72362073 |
| 52 | Hypergammaglobulinemia (HP:0010702) | 2.70673829 |
| 53 | Recurrent cutaneous fungal infections (HP:0011370) | 2.69883506 |
| 54 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.69883506 |
| 55 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.66382085 |
| 56 | Increased IgE level (HP:0003212) | 2.64283032 |
| 57 | Abnormality of the prostate (HP:0008775) | 2.63581572 |
| 58 | Lymphopenia (HP:0001888) | 2.61122917 |
| 59 | Thyroiditis (HP:0100646) | 2.60893550 |
| 60 | Sepsis (HP:0100806) | 2.59691449 |
| 61 | Joint hemorrhage (HP:0005261) | 2.58954997 |
| 62 | Chest pain (HP:0100749) | 2.58177633 |
| 63 | Urticaria (HP:0001025) | 2.57621607 |
| 64 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.54346263 |
| 65 | Bronchiectasis (HP:0002110) | 2.52505730 |
| 66 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.51994585 |
| 67 | Absent/shortened dynein arms (HP:0200106) | 2.51994585 |
| 68 | Keratoconjunctivitis sicca (HP:0001097) | 2.50149916 |
| 69 | Tetraparesis (HP:0002273) | 2.48939839 |
| 70 | Abnormality of the axillary hair (HP:0100134) | 2.46790543 |
| 71 | Abnormality of secondary sexual hair (HP:0009888) | 2.46790543 |
| 72 | Arterial thrombosis (HP:0004420) | 2.41354350 |
| 73 | Esophageal varix (HP:0002040) | 2.38196335 |
| 74 | Hypoplasia of the thymus (HP:0000778) | 2.38147182 |
| 75 | Emphysema (HP:0002097) | 2.37567011 |
| 76 | Acute lymphatic leukemia (HP:0006721) | 2.37529198 |
| 77 | Gangrene (HP:0100758) | 2.37462254 |
| 78 | Alopecia of scalp (HP:0002293) | 2.36375731 |
| 79 | Chronic otitis media (HP:0000389) | 2.35705454 |
| 80 | Abnormality of the pleura (HP:0002103) | 2.35385153 |
| 81 | Complement deficiency (HP:0004431) | 2.34392115 |
| 82 | Interstitial pulmonary disease (HP:0006530) | 2.34118284 |
| 83 | Premature loss of primary teeth (HP:0006323) | 2.30908041 |
| 84 | Myocardial infarction (HP:0001658) | 2.30520096 |
| 85 | Basal ganglia calcification (HP:0002135) | 2.29696403 |
| 86 | Hemoptysis (HP:0002105) | 2.29557865 |
| 87 | B lymphocytopenia (HP:0010976) | 2.28480099 |
| 88 | Abnormality of B cell number (HP:0010975) | 2.28480099 |
| 89 | Lymphoma (HP:0002665) | 2.24908439 |
| 90 | Keratoconjunctivitis (HP:0001096) | 2.24614450 |
| 91 | Abnormality of complement system (HP:0005339) | 2.23581986 |
| 92 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.22975760 |
| 93 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.22975760 |
| 94 | Abnormality of glycolipid metabolism (HP:0010969) | 2.22975760 |
| 95 | Nephritis (HP:0000123) | 2.22935121 |
| 96 | Nonimmune hydrops fetalis (HP:0001790) | 2.22786953 |
| 97 | Abnormality of T cell number (HP:0011839) | 2.21748497 |
| 98 | Encephalitis (HP:0002383) | 2.19589484 |
| 99 | Abnormality of T cell physiology (HP:0011840) | 2.19027803 |
| 100 | Joint swelling (HP:0001386) | 2.18649195 |
| 101 | IgM deficiency (HP:0002850) | 2.17594742 |
| 102 | IgA deficiency (HP:0002720) | 2.15694179 |
| 103 | Pulmonary embolism (HP:0002204) | 2.12307212 |
| 104 | Eosinophilia (HP:0001880) | 2.12186249 |
| 105 | Skin rash (HP:0000988) | 2.11723081 |
| 106 | Increased IgM level (HP:0003496) | 2.11429295 |
| 107 | Abnormality of T cells (HP:0002843) | 2.10884025 |
| 108 | Prolonged bleeding time (HP:0003010) | 2.10346874 |
| 109 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.10233375 |
| 110 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.10233375 |
| 111 | Blepharitis (HP:0000498) | 2.09626888 |
| 112 | Polycythemia (HP:0001901) | 2.08900874 |
| 113 | Leukocytosis (HP:0001974) | 2.08668419 |
| 114 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.08281028 |
| 115 | Restrictive lung disease (HP:0002091) | 2.08107640 |
| 116 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 2.07738813 |
| 117 | Acute hepatic failure (HP:0006554) | 2.06402377 |
| 118 | Purpura (HP:0000979) | 2.06346565 |
| 119 | Skin ulcer (HP:0200042) | 2.05719046 |
| 120 | Gingival bleeding (HP:0000225) | 2.05085270 |
| 121 | Abnormal ciliary motility (HP:0012262) | 2.03673316 |
| 122 | T lymphocytopenia (HP:0005403) | 2.03267164 |
| 123 | Combined immunodeficiency (HP:0005387) | 2.02548997 |
| 124 | Abnormality of the nasal mucosa (HP:0000433) | 2.01747502 |
| 125 | Chronic sinusitis (HP:0011109) | 2.01411074 |
| 126 | Verrucae (HP:0200043) | 2.00979647 |
| 127 | Papilloma (HP:0012740) | 2.00979647 |
| 128 | Thrombocytosis (HP:0001894) | 1.99223233 |
| 129 | Autoimmune hemolytic anemia (HP:0001890) | 1.99142676 |
| 130 | Petechiae (HP:0000967) | 1.98476925 |
| 131 | Dysostosis multiplex (HP:0000943) | 1.97772845 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K14 | 4.19228921 |
| 2 | BLK | 3.93000505 |
| 3 | KDR | 3.81129134 |
| 4 | MAP4K1 | 3.71250831 |
| 5 | TIE1 | 3.11330021 |
| 6 | IRAK3 | 3.01111756 |
| 7 | ERN1 | 2.69303782 |
| 8 | RIPK4 | 2.61412089 |
| 9 | PRPF4B | 2.39850002 |
| 10 | TBK1 | 2.38504254 |
| 11 | MST1R | 2.37425794 |
| 12 | TYK2 | 2.21100655 |
| 13 | TGFBR2 | 2.11275528 |
| 14 | MST4 | 2.09065063 |
| 15 | TXK | 2.04262426 |
| 16 | PIK3CG | 2.00860477 |
| 17 | JAK1 | 1.91472388 |
| 18 | IKBKB | 1.91303653 |
| 19 | IKBKE | 1.89004285 |
| 20 | PIK3CA | 1.84077700 |
| 21 | CSK | 1.74850180 |
| 22 | STK10 | 1.70531633 |
| 23 | JAK3 | 1.64296881 |
| 24 | MAP3K13 | 1.60780327 |
| 25 | IRAK4 | 1.58850068 |
| 26 | LYN | 1.53135192 |
| 27 | PBK | 1.48502714 |
| 28 | FRK | 1.38871578 |
| 29 | GRK6 | 1.38141407 |
| 30 | RIPK1 | 1.34932375 |
| 31 | SYK | 1.31476814 |
| 32 | OBSCN | 1.30676130 |
| 33 | FGFR3 | 1.27290631 |
| 34 | MAP3K10 | 1.26562755 |
| 35 | ZAP70 | 1.24750761 |
| 36 | TESK2 | 1.21387568 |
| 37 | KIT | 1.17987423 |
| 38 | CSF1R | 1.15693373 |
| 39 | PIM1 | 1.13049541 |
| 40 | BTK | 1.11739159 |
| 41 | GRK1 | 1.09210134 |
| 42 | MARK3 | 1.06179930 |
| 43 | HCK | 1.05020102 |
| 44 | TLK1 | 1.04797533 |
| 45 | NUAK1 | 1.04383226 |
| 46 | TEC | 1.02448925 |
| 47 | CHUK | 1.02116231 |
| 48 | MATK | 1.01036575 |
| 49 | CLK1 | 0.99665535 |
| 50 | LCK | 0.99139418 |
| 51 | BMPR2 | 0.98430961 |
| 52 | MAP2K3 | 0.91760230 |
| 53 | FGR | 0.88793506 |
| 54 | CDK9 | 0.87438231 |
| 55 | GRK7 | 0.87201494 |
| 56 | HIPK2 | 0.85045242 |
| 57 | EIF2AK3 | 0.84847686 |
| 58 | NLK | 0.83745953 |
| 59 | IRAK1 | 0.83120709 |
| 60 | MAPK7 | 0.83110293 |
| 61 | MAPK12 | 0.82359032 |
| 62 | INSRR | 0.81162585 |
| 63 | STK3 | 0.79786533 |
| 64 | LMTK2 | 0.79512223 |
| 65 | FGFR4 | 0.78680566 |
| 66 | TGFBR1 | 0.78560908 |
| 67 | MAP3K11 | 0.77866941 |
| 68 | YES1 | 0.75144941 |
| 69 | BMX | 0.74285933 |
| 70 | ACVR1B | 0.74192007 |
| 71 | PRKG2 | 0.71737761 |
| 72 | FES | 0.71498571 |
| 73 | MAP2K2 | 0.70893068 |
| 74 | TAOK2 | 0.70591250 |
| 75 | PDK1 | 0.70269590 |
| 76 | JAK2 | 0.70245567 |
| 77 | EIF2AK2 | 0.68394106 |
| 78 | CDK12 | 0.67843855 |
| 79 | MAP3K1 | 0.67714099 |
| 80 | STK24 | 0.67437257 |
| 81 | TRPM7 | 0.58871525 |
| 82 | MOS | 0.58426845 |
| 83 | PRKCQ | 0.56900920 |
| 84 | PRKCD | 0.56852562 |
| 85 | IGF1R | 0.55467811 |
| 86 | LRRK2 | 0.55050511 |
| 87 | CDK6 | 0.53910531 |
| 88 | TAOK3 | 0.53648049 |
| 89 | CDC42BPA | 0.53613270 |
| 90 | MUSK | 0.52487569 |
| 91 | MAP3K5 | 0.51945789 |
| 92 | STK4 | 0.51938649 |
| 93 | ITK | 0.51466847 |
| 94 | MAPK15 | 0.51141622 |
| 95 | ABL1 | 0.49775188 |
| 96 | EGFR | 0.49381194 |
| 97 | MELK | 0.48327546 |
| 98 | MAPK11 | 0.48293306 |
| 99 | CDK3 | 0.47374215 |
| 100 | RPS6KA5 | 0.47278777 |
| 101 | LATS1 | 0.46161497 |
| 102 | MAP3K3 | 0.45849697 |
| 103 | EPHA3 | 0.44632074 |
| 104 | ADRBK2 | 0.44401081 |
| 105 | MAP3K7 | 0.42720461 |
| 106 | MAP2K6 | 0.42550646 |
| 107 | TAOK1 | 0.40973220 |
| 108 | PTK6 | 0.40794300 |
| 109 | BCKDK | 0.40123833 |
| 110 | SIK3 | 0.40002273 |
| 111 | INSR | 0.39285008 |
| 112 | EPHB1 | 0.38278398 |
| 113 | MARK2 | 0.37830738 |
| 114 | PIM2 | 0.36172031 |
| 115 | BRD4 | 0.35762309 |
| 116 | TNK2 | 0.34291438 |
| 117 | BMPR1B | 0.34267802 |
| 118 | FYN | 0.33342943 |
| 119 | MAPK4 | 0.33316113 |
| 120 | MET | 0.32712176 |
| 121 | SGK3 | 0.32538411 |
| 122 | PKN1 | 0.32325049 |
| 123 | MAPK3 | 0.31877143 |
| 124 | PRKAA2 | 0.31842812 |
| 125 | SIK2 | 0.30222726 |
| 126 | NEK9 | 0.29932994 |
| 127 | CDK4 | 0.29401691 |
| 128 | RPS6KA4 | 0.29294085 |
| 129 | EPHB2 | 0.28151221 |
| 130 | MAPKAPK2 | 0.28031175 |
| 131 | MAP2K1 | 0.27855173 |
| 132 | SGK2 | 0.27490134 |
| 133 | PDPK1 | 0.25791058 |
| 134 | RPS6KB2 | 0.24239735 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.72502870 |
| 2 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.02675904 |
| 3 | Leishmaniasis_Homo sapiens_hsa05140 | 3.00593555 |
| 4 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.75500162 |
| 5 | Malaria_Homo sapiens_hsa05144 | 2.61695671 |
| 6 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.44306532 |
| 7 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.44186397 |
| 8 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.33797310 |
| 9 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.30429839 |
| 10 | African trypanosomiasis_Homo sapiens_hsa05143 | 2.29395078 |
| 11 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.28422533 |
| 12 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.26357535 |
| 13 | Pertussis_Homo sapiens_hsa05133 | 2.22210617 |
| 14 | Legionellosis_Homo sapiens_hsa05134 | 2.17231651 |
| 15 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.13514831 |
| 16 | * Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.10588548 |
| 17 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.04787941 |
| 18 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.04184785 |
| 19 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.81204087 |
| 20 | Salmonella infection_Homo sapiens_hsa05132 | 1.76055985 |
| 21 | Measles_Homo sapiens_hsa05162 | 1.75292945 |
| 22 | Tuberculosis_Homo sapiens_hsa05152 | 1.75022802 |
| 23 | Allograft rejection_Homo sapiens_hsa05330 | 1.68480623 |
| 24 | Influenza A_Homo sapiens_hsa05164 | 1.67307487 |
| 25 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.64641640 |
| 26 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.60803946 |
| 27 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.54512743 |
| 28 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.53493214 |
| 29 | Mineral absorption_Homo sapiens_hsa04978 | 1.43903061 |
| 30 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.40790960 |
| 31 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.32885273 |
| 32 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.29208339 |
| 33 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.29134630 |
| 34 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.26723493 |
| 35 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.25902397 |
| 36 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.25045158 |
| 37 | Asthma_Homo sapiens_hsa05310 | 1.19293820 |
| 38 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.18374719 |
| 39 | Hepatitis C_Homo sapiens_hsa05160 | 1.09874196 |
| 40 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.09503467 |
| 41 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.06166021 |
| 42 | Bile secretion_Homo sapiens_hsa04976 | 1.00225729 |
| 43 | Other glycan degradation_Homo sapiens_hsa00511 | 0.98487513 |
| 44 | Lysosome_Homo sapiens_hsa04142 | 0.91739339 |
| 45 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.90287819 |
| 46 | * Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.88504809 |
| 47 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.88490286 |
| 48 | * Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.87030706 |
| 49 | Apoptosis_Homo sapiens_hsa04210 | 0.83567549 |
| 50 | Shigellosis_Homo sapiens_hsa05131 | 0.83134327 |
| 51 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.82513741 |
| 52 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.81098869 |
| 53 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.77852823 |
| 54 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.77483422 |
| 55 | Hepatitis B_Homo sapiens_hsa05161 | 0.77020464 |
| 56 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.75917656 |
| 57 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.75663896 |
| 58 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.74977772 |
| 59 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.73471472 |
| 60 | Viral myocarditis_Homo sapiens_hsa05416 | 0.73248929 |
| 61 | Platelet activation_Homo sapiens_hsa04611 | 0.72498920 |
| 62 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.72430935 |
| 63 | Prion diseases_Homo sapiens_hsa05020 | 0.72363344 |
| 64 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.70117797 |
| 65 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.68747324 |
| 66 | Phagosome_Homo sapiens_hsa04145 | 0.68462353 |
| 67 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.67943800 |
| 68 | Amoebiasis_Homo sapiens_hsa05146 | 0.67856565 |
| 69 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.67609175 |
| 70 | HTLV-I infection_Homo sapiens_hsa05166 | 0.62108989 |
| 71 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.61433621 |
| 72 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.59467123 |
| 73 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.59285106 |
| 74 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.57185929 |
| 75 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.57108059 |
| 76 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.57058971 |
| 77 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.56056017 |
| 78 | ABC transporters_Homo sapiens_hsa02010 | 0.53614818 |
| 79 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.52238262 |
| 80 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.51664760 |
| 81 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.50957395 |
| 82 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.48715800 |
| 83 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.47265010 |
| 84 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.46298431 |
| 85 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.37802362 |
| 86 | Adherens junction_Homo sapiens_hsa04520 | 0.34917826 |
| 87 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.34485098 |
| 88 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.32530923 |
| 89 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.32514203 |
| 90 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.32252316 |
| 91 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.31499714 |
| 92 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.31103812 |
| 93 | Peroxisome_Homo sapiens_hsa04146 | 0.30907687 |
| 94 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.30718617 |
| 95 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.30377562 |
| 96 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.28713078 |
| 97 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.28638089 |
| 98 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.27228113 |
| 99 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.27208774 |
| 100 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.25604372 |
| 101 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.24574385 |
| 102 | Insulin resistance_Homo sapiens_hsa04931 | 0.23655577 |
| 103 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.23303854 |
| 104 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.22890331 |
| 105 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.22847175 |
| 106 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.22291036 |
| 107 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.21016279 |
| 108 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.20074231 |
| 109 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.19843056 |
| 110 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.19219499 |
| 111 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.18890750 |
| 112 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.18571905 |
| 113 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.17619721 |
| 114 | Histidine metabolism_Homo sapiens_hsa00340 | 0.17154138 |
| 115 | Alcoholism_Homo sapiens_hsa05034 | 0.15649870 |
| 116 | Prostate cancer_Homo sapiens_hsa05215 | 0.12259070 |
| 117 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.11900729 |
| 118 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.08699163 |
| 119 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.06588640 |
| 120 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.04290049 |
| 121 | Olfactory transduction_Homo sapiens_hsa04740 | 0.03734712 |
| 122 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.03714301 |
| 123 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.03362833 |
| 124 | Renin secretion_Homo sapiens_hsa04924 | 0.02805826 |
| 125 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.02437449 |
| 126 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.01482073 |
| 127 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.00381280 |
| 128 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | -0.0025460 |

